Bibliography

Found 1068 results
2009
Wiederin J, Rozek W, Duan F, Ciborowski P. Biomarkers of HIV-1 associated dementia: proteomic investigation of sera. Proteome Science [Internet]. 2009 ;7:8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19292902
Ciborowski P. Biomarkers of HIV-1-associated neurocognitive disorders: challenges of proteomic approaches. Biomark Med [Internet]. 2009 ;3:771-85. Available from: http://www.ncbi.nlm.nih.gov/pubmed?term=%20%20%20%2020477714
Gelman B, Chen T, Lisinicchia JG, Carmical JR, Starkey JM, Luxon BA, Morgello S, Masliah E, Commins D, Brandt D, et al. Brain gene array reveals CNS adaptation and two different kinds of HIV-associated neurocognitive disorder. In: American Association of Neuropathologists 85 Annual Meeting. American Association of Neuropathologists 85 Annual Meeting. San Antonio, Texas; 2009. p. abstract #95.
Bachis A, Avdoshina V, Liu C, Young MA, Mocchetti I. Brain-derived neurotrophic factor levels are reduced in the brain and blood of HIV-1 positive subjects. 2009 ;534.14/M21.
Levine AJ, Singer EJ, Benard S, Sinsheimer JS, Giovanelli A. A candidate gene study of HIV-dementia in the National NeuroAIDS Tissue Consortium. In: 2nd Annual AIDS Research Symposium at UCLA. 2nd Annual AIDS Research Symposium at UCLA. ; 2009.
Levine AJ, Singer EJ, Sinsheimer JS, Hinkin CH, Papp J, Dandekar S, Giovanelli A, Shapshak P. CCL3 genotype and current depression increase risk of HIV-associated dementia. Neurobehavioral HIV Medicine [Internet]. 2009 ;1:1-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20725607
Brown A, Skolasky RL, Marder K, Cohen BA, Schifito G, Creighton J, Guo L, McArthur JC. CCL3L1 gene copy number in the Northeast AIDS Dementia (NEAD) Cohort and the National NeuroAIDS Tissue Consortium (NNTC). In: Conference on Retroviruses. Conference on Retroviruses. ; 2009.
Kou W, Banerjee S, Eudy J, Smith LM, Persidsky R, Borgmann K, Wu L, Sakhuja N, Deshpande MS, Walseth TF, et al. CD38 regulation in activated astrocytes: Implications for neuroinflammation and HIV-1 brain infection. J Neurosci Res [Internet]. 2009 ;87:2326-2339. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19365854
Everall I, Vaida F, Khanlou N, Lazzaretto D, Achim C, Letendre S, Moore D, Ellis RJ, Cherner M, Gelman B, et al. Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. Journal of Neurovirology [Internet]. 2009 ;15:360-70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20175693
Levine AJ, Singer EJ, Bilder R, Shapshak P, Sinsheimer JS. COMT val168met polymorphism confers risk for working memory impairment in HIV. In: Third Meeting on HIV Infection and the Central Nervous System. Third Meeting on HIV Infection and the Central Nervous System. Stresa, Italy; 2009.
Clifford DB, Fagan AM, Holtzman DM, Morris JC, Teshome M, Shah AR, Kauwe JSK. CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease. Neurology. 2009 ;73(23):1982-7.
Tan CS, Dezube BJ, Bhargava P, Autissier P, Wüthrich C, Miller JS, Koralnik IJ. Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation. The Journal of Infectious Diseases [Internet]. 2009 ;199:881-888. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19434914
Heron PM, Turchan-Cholewo J, Bruce-Keller AJ, Wilson ME. Estrogen receptor alpha inhibits the estrogen-mediated suppression of HIV transcription in astrocytes: implications for estrogen neuroprotection in HIV dementia. AIDS Res Hum Retroviruses [Internet]. 2009 ;25:1071-81. Available from: http://www.ncbi.nlm.nih.gov/pubmed?term=Estrogen%20receptor%20alpha%20inhibits%20the%20estrogen-mediated%20suppression%20of%20HIV%20transcription%20in%20astrocytes%3A%20implications%20for%20estrogen%20neuroprotection%20in%20HIV%20dementia
Cosenza-Nashat MA, Zhao ML, Suh H-S, Morgan J, Natividad R, Morgello S, Lee SC. Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain. Neuropathology and Applied Neurobiology [Internet]. 2009 ;35:306-328. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19077109
Wüthrich C, Cheng YM, Joseph J, Kesari S, Beckwith C, Stopa EG, Bell JE, Koralnik IJ. Frequent infection of cerebellar granule cell neurons by polyomavirus JC in progressive multifocal leukoencephalopathy. Journal of Neuropathology and Experimental Neurology [Internet]. 2009 ;68:15-25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19104450
Yuferov V, Ji F, Nielsen DA, Levran O, Ho A, Morgello S, Shi R, Ott J, Kreek MJ. A functional haplotype implicated in vulnerability to develop cocaine dependence is associated with reduced PDYN expression in human brain. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology [Internet]. 2009 ;34:1185-1197. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18923396
Paltin I. The Functional Impact of HIV-related Neuropsychiatric Comorbidity in HIV/AIDS. 2009 .
Kallianpur AR, Hulgan T, Wen W, Canter JA, Haas DW, Gelman B. Hemochromatosis (HFE) Gene Polymorphisms and HIV-Associated Brain Pathology at Autopsy: Results of a NeuroAIDS DNA Bank Study. Jounral of Neurovirology. 2009 .
Wilkinson J, Radkowski M, Laskus T. Hepatitis C virus neuroinvasion: identification of infected cells. Journal of Virology [Internet]. 2009 ;83:1312-1319. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19019968
Kumar A. HIV-1 in the CNS causes dopaminergic deficits in multiple regions: Implications on neurocognition. In: 9th International Symposium on NeuroVirology. 9th International Symposium on NeuroVirology. Miami Beach, FL; 2009.
Wiederin J, Duan F, Rozek W, Ciborowski P. HIV-infected patients with neurocognitive impairments: Proteomic fingerprints of serum/plasma and CSF. In: 57th ASMS Conference on Mass Spectrometry. 57th ASMS Conference on Mass Spectrometry. Philadelphia, PA; 2009.
Kumar A, Fernandez JB, Singer EJ, Commins D, Waldrop-Valverde D, Ownby RL, Kumar M. Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains. Journal of Neurovirology [Internet]. 2009 ;15(3):257-274. Available from: http://link.springer.com/article/10.1080%2F13550280902973952
Khanlou N, Moore D, Chana G, Cherner M, Lazzaretto D, Dawes S, Grant I, Masliah E, Everall I. Increased frequency of alpha-synuclein in the substantia nigra in human immunodeficiency virus infection. Journal of Neurovirology [Internet]. 2009 ;15:131-138. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19115126

Pages